Skip to main content
Clinical Trials/NCT05109897
NCT05109897
Unknown
N/A

Influencing Factors and Improving Strategy on Gait Variability in People With Parkinson's Disease

National Yang Ming Chiao Tung University1 site in 1 country100 target enrollmentNovember 1, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Parkinson Disease
Sponsor
National Yang Ming Chiao Tung University
Enrollment
100
Locations
1
Primary Endpoint
Walking speed
Last Updated
4 years ago

Overview

Brief Summary

The principal motor features of Parkinson's disease (PD) include rigidity, tremor, bradykinesia, and postural instability. These motor deficits might cause gait dysfunction including reduced gait velocity, stride length, arm swing, and increased gait variability. Among these, increase in gait variability increased fall risk and served as a marker of disease progression. Previous studies reported that some factors might influence gait variability. However, which one contributes most has not yet been verified. Therefore, the purpose of the present study is to identify the more related influencing factors on gait variability in people with PD.

Registry
clinicaltrials.gov
Start Date
November 1, 2021
End Date
December 31, 2022
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Yea-Ru Yang

Professor

National Yang Ming Chiao Tung University

Eligibility Criteria

Inclusion Criteria

  • Idiopathic PD
  • Hoehn and Yahr stages I through III
  • Ability to stand and walk 5 m independently with or without any walking aids
  • Stable medication usage

Exclusion Criteria

  • Unstable medical conditions
  • Any neurological, cardiopulmonary or orthopedic problem/diseases that may interfere with participating the study

Outcomes

Primary Outcomes

Walking speed

Time Frame: 10 minutes

Using GAITRite system to evaluate

Sensory organization test

Time Frame: 20 minutes

Using NeuroCom Smart Balance Master to measure

Part III of the Unified Parkinson's Disease Rating Scale

Time Frame: 20 minutes

The score ranged from 0 to 72. Higher scores show increased severity.

Montreal Cognitive Assessment

Time Frame: 20 minutes

The score ranged from 0 to 30. Higher scores show better cognitive function.

Gait variability

Time Frame: 10 minutes

Using GAITRite system to measure coefficient of variation

Tinetti Balance Scale

Time Frame: 10 minutes

The score ranged from 0 to 28. Higher scores show better balance.

New freezing of gait questionnaire

Time Frame: 15 minutes

The score ranged from 0 to 29. Higher scores show increased severity in freezing of gait.

Study Sites (1)

Loading locations...

Similar Trials